EVALUATION OF THE LEVELS OF FREE AND TOTAL AMITRIPTYLINE AND METABOLITES IN THE PLASMA AND BRAIN OF THE RAT AFTER LONG-TERM ADMINISTRATION OF DOSES USED IN RECEPTOR STUDIES

被引:33
作者
BAUMANN, P [1 ]
GAILLARD, JM [1 ]
JONZIERPEREY, M [1 ]
GERBER, C [1 ]
BOURAS, C [1 ]
机构
[1] UNIV BEL AIR, PSYCHIAT CLIN, CH-1225 CHENE BOURG, SWITZERLAND
关键词
D O I
10.1007/BF00431455
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The level of amitriptyline (AT) and its metabolites was investigated. Three separate experiments were carried out. In 2 of these experiments, rats were treated over 7 days with i.p. doses of AT (10 mg/kg in experiment A and 2 .times. 20 mg/kg in experiment C). The rats were sacrificed 2 (experiment C) or 12 h (experiments A and C) after the last dose. In experiment B, rats were sacrificed 2 or 12 h after a single dose of 20 mg/kg AT. In experiment A only AT was measurable in the brain and in the plasma, in contrast to experiments B and C, where NT and the hydroxylated metabolites AT-OH and NT-OH reached significant levels in the plasma and in the brain. The concentrations of AT-OH, NT-OH and NT (12-h values) that were found in the brain are probably not pharmacologically relevant. The 12-h plasma values of all compounds tested were, even with the highest dose, lower than those expected to be clinically effective in man. Apparently, AT, at higher doses, may induce its own metabolism. The free plasma levels of this drug and its metabolites are higher in man than in the rat. The possible implications of these results in the use of antidepressants in the treatment of depression are discussed.
引用
收藏
页码:489 / 495
页数:7
相关论文
共 52 条
[1]   AMITRIPTYLINE SENSITIZATION OF A SEROTONIN-MEDIATED BEHAVIOR DEPENDS ON THE PASSAGE OF TIME AND NOT REPEATED TREATMENT [J].
ANTELMAN, SM ;
DEGIOVANNI, LA ;
KOCAN, D ;
PEREL, JM ;
CHIODO, LA .
LIFE SCIENCES, 1983, 33 (17) :1727-1730
[2]  
ANTELMAN SM, 1981, BIOL PSYCHIAT, V16, P717
[3]  
BAUMANN P, 1982, European Journal of Mass Spectrometry in Biochemistry Medicine and Environmental Research, V2, P19
[4]   RELATIONSHIPS BETWEEN BRAIN CONCENTRATIONS OF DESIPRAMINE AND PARADOXICAL SLEEP INHIBITION IN THE RAT [J].
BAUMANN, P ;
GAILLARD, JM ;
PEREY, M ;
JUSTAFRE, JC ;
LE, P .
JOURNAL OF NEURAL TRANSMISSION, 1983, 56 (2-3) :105-116
[5]  
BAUMANN P, 1984, FORSCHUNGEN BIOL PSY, P298
[6]  
BAUMANN P, 1983, CLIN PHARM PSYCHIATR, P227
[7]   PRONOUNCED INHIBITION OF NORADRENALINE UPTAKE BY 10-HYDROXY-METABOLITES OF NORTRIPTYLINE [J].
BERTILSSON, L ;
MELLSTROM, B ;
SJOQVIST, F .
LIFE SCIENCES, 1979, 25 (15) :1285-1292
[8]   PERAZINE, CHLORPROMAZINE AND IMIPRAMINE AS INDUCERS OF MICROSOMAL DRUG-METABOLISM [J].
BREYER, U .
NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE, 1972, 272 (03) :277-&
[9]   ANTIDEPRESSIVE EFFECT AND PHARMACOKINETICS OF AMITRIPTYLINE WITH CONSIDERATION OF UN-BOUND DRUG AND 10-HYDROXYNORTRIPTYLINE PLASMA-LEVELS [J].
BREYERPFAFF, U ;
GAERTNER, HJ ;
KREUTER, F ;
SCHAREK, G ;
BRINKSCHULTE, M ;
WIATR, R .
PSYCHOPHARMACOLOGY, 1982, 76 (03) :240-244
[10]   DISTRIBUTION OF C14-LABELLED AMITRIPTYLINE IN CAT BRAIN [J].
CASSANO, GB ;
SJOSTRAND, SE ;
HANSSON, E .
PSYCHOPHARMACOLOGIA, 1965, 8 (01) :12-+